Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Proteins and Peptides

Beta Synuclein Monomers

Product Sizes
100 ug
SPR-405-100UG
2 x 100 ug
SPR-405-2X100UG
5 x 100 ug
SPR-405-5X100UG
About this Product
SKU:
SPR-405
Additional Names:
Beta-synuclein, Synuclein beta, SNCB, SYUB_HUMAN, PNP14, Phosphoneuroprotein 14, 14 kDa brain-specific, G Protein Beta1/Gamma2 Subunit-Interacting Factor 1
Application:
Cell-based/Functional Assay, SDS-PAGE, Western Blot
Buffer:
PBS
CE/IVD:
RUO
Concentration:
2 mg/ml
Extra Details:
Beta-synuclein, a soluble neuronal protein encoded by the SNCB gene, is increasingly recognized for its pivotal role in neurodegenerative disease research. Unlike its aggregation-prone counterpart alpha-synuclein, beta-synuclein monomers exhibit neuroprotective properties and are less likely to form toxic fibrils. Recent studies highlight beta-synuclein's involvement in synaptic plasticity, regulation of dopamine metabolism, and inhibition of neuronal apoptosis. [www.uniprot.org] In Alzheimer's disease (AD) and Lewy body dementia (LBD), elevated beta-synuclein levels in cerebrospinal fluid (CSF) and serum correlate with synaptic degeneration and disease progression. Novel assays targeting distinct epitopes of beta-synuclein have demonstrated its diagnostic potential, distinguishing early-stage AD from mild cognitive impairment and dementia. Furthermore, beta-synuclein's dynamic expression across disease stages positions it as a promising biomarker for staging and monitoring neurodegeneration. [jnnp.bmj.com] Mechanistically, beta-synuclein modulates the phase behavior of alpha-synuclein, delaying its transition into neurotoxic aggregates. This regulatory function suggests a protective role in maintaining synaptic integrity and preventing pathological protein aggregation. [jnnp.bmj.com] As research advances, beta-synuclein monomers are emerging not only as biomarkers but also as potential therapeutic targets. Their unique biochemical properties and disease-specific expression patterns underscore their relevance in precision medicine approaches for neurodegenerative disorders.
Immunogen:
Beta Synuclein Monomers
Molecular Weight:
14.28 kDa
Purity:
>95%
Purification:
Ion Exchange
Shipping Conditions:
Dry Ice
Storage Conditions:
-70[o]C
Supplier:
StressMarq Biosciences
Type:
Proteins, Peptides, Small Molecules & Other Biomolecules: Recombinant Proteins